ReP USP - Resultado da busca

Artigo de periodico
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies (2022)
Gil-Vila, Albert; Ravichandran, Naveen; Selva-O'callaghan, Albert; Sen, Parikshit; Nune, Arvind; Gaur, Prithvi Sanjeevkumar; Gonzalez, Raquel Aranega; Lilleker, James B; Joshi, Mrudula; Shinjo, Samuel Katsuyuki
Source: Muscle & nerve. Unidade: FM
Subjects: COVID-19, DERMATOPATIAS, MIOSITE, REUMATOLOGIA, VACINAÇÃO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIL-VILA, Albert et al. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle & nerve, v. 66, n. 4, p. 426-437, 2022Tradução . . Disponível em: https://doi.org/10.1002/mus.27681. Acesso em: 27 set. 2024.
APA
Gil-Vila, A., Ravichandran, N., Selva-O'callaghan, A., Sen, P., Nune, A., Gaur, P. S., et al. (2022). COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle & nerve, 66( 4), 426-437. doi:10.1002/mus.27681
NLM
Gil-Vila A, Ravichandran N, Selva-O'callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, Lilleker JB, Joshi M, Shinjo SK. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies [Internet]. Muscle & nerve. 2022 ; 66( 4): 426-437.[citado 2024 set. 27 ] Available from: https://doi.org/10.1002/mus.27681
Vancouver
Gil-Vila A, Ravichandran N, Selva-O'callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, Lilleker JB, Joshi M, Shinjo SK. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies [Internet]. Muscle & nerve. 2022 ; 66( 4): 426-437.[citado 2024 set. 27 ] Available from: https://doi.org/10.1002/mus.27681
Artigo de periodico
COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis (2022)
Faria, M. S. M. S; Shinjo, Samuel Katsuyuki
Source: Reumatismo. Unidade: FM
Subjects: COVID-19, REUMATOLOGIA, MIOSITE, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIA, M. S. M. S e SHINJO, Samuel Katsuyuki. COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis. Reumatismo, v. 74, n. 1, p. 41-43, 2022Tradução . . Disponível em: https://doi.org/10.4081/reumatismo.2022.1440. Acesso em: 27 set. 2024.
APA
Faria, M. S. M. S., & Shinjo, S. K. (2022). COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis. Reumatismo, 74( 1), 41-43. doi:10.4081/reumatismo.2022.1440
NLM
Faria MSMS, Shinjo SK. COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis [Internet]. Reumatismo. 2022 ; 74( 1): 41-43.[citado 2024 set. 27 ] Available from: https://doi.org/10.4081/reumatismo.2022.1440
Vancouver
Faria MSMS, Shinjo SK. COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis [Internet]. Reumatismo. 2022 ; 74( 1): 41-43.[citado 2024 set. 27 ] Available from: https://doi.org/10.4081/reumatismo.2022.1440
Artigo de periodico
Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis (2022)
Hoff, Leonardo S.; Souza, Fernando H. C. de; Miossi, Renata; Shinjo, Samuel Katsuyuki
Source: Rheumatology. Unidade: FM
Subjects: MIOSITE, REUMATOLOGIA, IMUNIDADE, MORTALIDADE, ADULTOS, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOFF, Leonardo S. et al. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis. Rheumatology, v. 61, n. 4, p. 1579-1588, 2022Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab597. Acesso em: 27 set. 2024.
APA
Hoff, L. S., Souza, F. H. C. de, Miossi, R., & Shinjo, S. K. (2022). Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis. Rheumatology, 61( 4), 1579-1588. doi:10.1093/rheumatology/keab597
NLM
Hoff LS, Souza FHC de, Miossi R, Shinjo SK. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis [Internet]. Rheumatology. 2022 ; 61( 4): 1579-1588.[citado 2024 set. 27 ] Available from: https://doi.org/10.1093/rheumatology/keab597
Vancouver
Hoff LS, Souza FHC de, Miossi R, Shinjo SK. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis [Internet]. Rheumatology. 2022 ; 61( 4): 1579-1588.[citado 2024 set. 27 ] Available from: https://doi.org/10.1093/rheumatology/keab597

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies